References
Mundell I. QOL studies in epilepsy — worthwhile pursuit or waste of time? Inpharma 1994 Mar 12; (928): 3–4
Baker GA. Health-related quality-of-life issues: optimizing patient outcomes. Neurology 1995 Mar; 45 Suppl. 2: S29–34
Baker GA, Smith DF, Dewey M, et al. The initial development of a health-related quality of life model as an outcome measure in epilepsy. Epilep Res 1993 Sep; 16: 65–81
Vickery BG. Special issue: Advances in the measurement of health-related quality of life in epilepsy. Qual Life Res 1995 Apr; 4: 83–5
Scambler G. Epilepsy and quality of life research. J R Soc Med 1993 Aug; 86: 449–50
Baker GA. Improved quality of life as an outcome of antiepileptic drug therapy. Is it enough? CNS Drugs 1995 May; 3(5): 323–7
Erickson P, Taeuber RC, Scott J. Operational aspects of quality-of-life assessment: choosing the right instrument. PharmacoEconomics 1995 Jan; 7(1): 39–48
Jacoby A, Baker G, Smith D, et al. Measuring the impact of epilepsy: the development of a novel scale. Epilep Res 1993 Sep; 16: 83–8
Baker GA, Jacoby A, Smith DF, et al. Development of a novel scale to assess life fulfilment as part of the further refinement of a quality-of-life model for epilepsy. Epilepsia 1994 May–Jun; 35(3): 591–6
Schwartz CE, Cole BF, Vickery BG, et al. The Q-TWiST approach to assessing health-related quality of life in epilepsy. Qual Life Res 1995 Apr; 4: 135–41
Rights and permissions
About this article
Cite this article
Measure QOL in epilepsy to complement more traditional outcomes. Drugs Ther. Perspect 6, 14–16 (1995). https://doi.org/10.2165/00042310-199506050-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-199506050-00006